Coblation — CPB 0475 | AETNA Coverage Update

Aetna modified CPB 0475 for coblation tonsillectomy, effective September 26, 2025. Here's what billing teams need to know before that date.

Aetna, a CVS Health company, updated its coblation coverage policy under CPB 0475 to define four specific medical necessity criteria for coblation tonsillectomy. The policy now lists covered indications clearly — peri-tonsillar abscess, recurrent middle ear infection with tonsillar hypertrophy, recurrent or chronic tonsillar infection, and tonsillar hypertrophy causing respiratory symptoms or airway obstruction. If you bill CPT 30801, 30802, 30465, or 30469 for Aetna members, this update affects your documentation requirements and claim eligibility starting September 26, 2025.

Quick-Reference Table

Aetna Coblation Tonsillectomy Coverage Criteria and Medical Necessity Requirements 2025

Aetna's coblation tonsillectomy coverage policy under CPB 0475 is cleaner than most. Four indications qualify. If your patient's chart supports one of them, you have a clear path to reimbursement. If it doesn't, you're looking at a denial.

Aetna considers coblation tonsillectomy medically necessary for any one of these:

The real issue here is indication number two. "Believed to be an exacerbating factor" is soft language. Aetna will expect the treating physician to clearly document why tonsillar hypertrophy is contributing to the middle ear infections — not just note both conditions exist. A claims reviewer won't connect those dots for you.

Coblation billing under this policy lives or dies on documentation specificity. Vague notes like "recurrent infections, tonsillectomy planned" won't carry a claim. The note needs to name the indication and support it with clinical evidence.

Prior authorization requirements for coblation procedures vary by plan. Check individual plan benefits before scheduling. For Aetna commercial plans, prior auth is commonly required for surgical procedures in this category — don't assume it's not required just because the medical necessity criteria are met.

Aetna Coblation Exclusions and Non-Covered Indications

CPB 0475 explicitly flags CPT codes 64633 and +64634 as not covered for the indications listed in this policy. Those codes cover destruction by neurolytic agent for paravertebral facet joint nerve(s) with imaging guidance — they're in this CPB as related procedures, but Aetna draws a hard line. Don't bill them under a coblation indication expecting coverage.

The broader category of "Coblation non-thermal volumetric tissue reduction or radiofrequency" procedures tied to CPT 30465 and 30469 sits in a different group. These are nasal repair and reconstruction codes — nasal vestibular stenosis repair and nasal valve collapse treatment. Aetna does not group these with covered tonsillectomy indications under CPB 0475. If you're billing nasal procedures alongside a tonsillectomy, confirm each code stands on its own medical necessity criteria.

If you're unsure how your specific mix of codes applies under this policy, loop in your compliance officer before September 26, 2025.

Coverage Indications at a Glance

Aetna Coblation Billing Guidelines and Action Items 2025

1. Audit your open coblation tonsillectomy claims before September 26, 2025.
Pull every claim with CPT 30801 or 30802 that hasn't been submitted yet. Check that the documentation maps to one of the four covered indications. If the chart supports coverage, submit. If it doesn't, get an addendum from the treating physician before the claim goes out.

2. Update your charge capture templates for coblation tonsillectomy.
Your templates should prompt for indication-specific documentation — not just "tonsillectomy performed." Add a required field or checklist that forces selection of the covered indication and links to supporting clinical evidence.

3. Check prior authorization requirements by plan before scheduling.
Aetna commercial, Aetna Medicare Advantage, and employer-sponsored plans may have different prior auth rules. Verify prior authorization requirements for CPT 30801 and 30802 at the individual plan level. Don't treat this as a blanket rule across all Aetna products.

4. Train your ENT schedulers and coders on the middle ear infection indication.
The "recurrent middle ear infection where tonsillar hypertrophy is believed to be an exacerbating factor" criterion is the one most likely to generate denials. Schedulers need to flag these cases for extra documentation. Coders need to confirm the physician note explicitly draws the clinical connection.

5. Exclude CPT 64633 and +64634 from coblation claims.
These codes are explicitly not covered for indications in CPB 0475. If you're billing facet joint nerve destruction in the same encounter, keep it on a separate claim with its own medical necessity documentation. Bundling it with a coblation procedure creates claim denial risk.

6. Pull your denial history for coblation tonsillectomy going back 12 months.
Look at what Aetna denied and why. If the pattern shows documentation gaps on the four covered indications, that's your training target. If it shows prior auth misses, fix your workflow upstream at scheduling.

CPT, HCPCS, and ICD-10 Codes for Coblation Under CPB 0475

Covered CPT Codes (When Selection Criteria Are Met)

Not Covered / Separate Criteria Codes

Other CPT Codes Related to CPB 0475

These codes appear in the policy as related procedures. Coverage depends on the specific clinical scenario and applicable selection criteria — they don't automatically fall under the tonsillectomy indications.

The full policy lists 251 CPT codes and 358 ICD-10-CM codes. The complete code set is available in the CPB 0475 Aetna policy document. The policy data provided here includes the complete named codes above — the remaining codes in the policy are labeled as additional endoscopy/arthroscopy codes in the "Other CPT codes related to the CPB" group.

Key ICD-10-CM Diagnosis Codes

The full CPB 0475 Aetna system lists 358 ICD-10-CM codes. The policy data provided for this update did not include the individual code descriptions for the complete ICD-10 set. Access the full code list at the CPB 0475 source policy. For tonsillectomy billing, your primary ICD-10 codes will map to the four covered indications — peri-tonsillar abscess (J36), chronic tonsillitis (J35.01), recurrent tonsillitis, tonsillar hypertrophy (J35.1), and obstructive sleep apnea with tonsillar hypertrophy (G47.33) as applicable.

The Bottom Line on CPB 0475

This coverage policy is actually more billing-friendly than it might first appear. Four clear indications. No ambiguity about whether coblation itself is the issue — Aetna covers the technique when the indication is right. The risk isn't in the criteria. The risk is in documentation that doesn't explicitly support one of the four.

The middle ear infection indication will generate the most denials. Physicians need to articulate the clinical reasoning, not just list diagnoses. Your job as a billing team is to make that documentation requirement visible — in your templates, your scheduling workflows, and your coder checklists — before the effective date of September 26, 2025.